Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA056981-04S1
Application #
2097743
Study Section
Special Emphasis Panel (SRC (42))
Project Start
1992-05-01
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1998-03-31
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Urology
Type
Schools of Medicine
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Hemstreet 3rd, G P; Yin, S; Ma, Z et al. (2001) Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine. J Natl Cancer Inst 93:427-36
Waliszewski, P; Waliszewska, M; Gordon, N et al. (1999) Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells. Mol Cell Endocrinol 148:55-65
Bonner, R B; Liebert, M; Hurst, R E et al. (1996) Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer. Cancer Epidemiol Biomarkers Prev 5:971-8
Hemstreet 3rd, G P; Rao, J; Hurst, R E et al. (1996) G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J Cell Biochem Suppl 25:197-204
Rao, J Y; Hemstreet 3rd, G P; Hurst, R E et al. (1993) Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci U S A 90:8287-91